Comparing the relative safety and effectiveness of empagliflozin and linagliptin in patients with type 2 diabetes (T2D) using meta-analysis

Arjun Baidya, Asis Mitra, Saswati Ray, Mridul Bera, Kaushik Pahari, Rishad Ahmed

Open source

DOI: 10.5603/mrj.106865
Published: 2025-09-30
Container: Medical Research Journal
Publisher: VM Media Group sp. z o.o
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.5603/mrj.106865,
  title = {Comparing the relative safety and effectiveness of empagliflozin and linagliptin in patients with type 2 diabetes (T2D) using meta-analysis},
  author = {Arjun Baidya and Asis Mitra and Saswati Ray and Mridul Bera and Kaushik Pahari and Rishad Ahmed},
  year = {2025},
  journal = {Medical Research Journal},
  doi = {10.5603/mrj.106865},
  url = {https://doi.org/10.5603/mrj.106865}
}

RIS

TY  - JOUR
TI  - Comparing the relative safety and effectiveness of empagliflozin and linagliptin in patients with type 2 diabetes (T2D) using meta-analysis
AU  - Arjun Baidya
AU  - Asis Mitra
AU  - Saswati Ray
AU  - Mridul Bera
AU  - Kaushik Pahari
AU  - Rishad Ahmed
PY  - 2025
JO  - Medical Research Journal
DO  - 10.5603/mrj.106865
UR  - https://doi.org/10.5603/mrj.106865
ER  -

APA

Baidya, A., Mitra, A., Ray, S., Bera, M., Pahari, K., & Ahmed, R. (2025). Comparing the relative safety and effectiveness of empagliflozin and linagliptin in patients with type 2 diabetes (T2D) using meta-analysis. Medical Research Journal. https://doi.org/10.5603/mrj.106865

Source records

crossref · retrieved 2026-09-26T18:16:31.714Z